MYCN and B-cell non-Hodgkin lymphoma: I would be expected that MYCN overexpressing tumors would have elevated rates of ribosome biogenesis, and their malignancy dependent on this process as has been described in c-Myc-driven tumors model of B-cell lymphoma [19].